Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632644 · ClinicalTrials.gov registry record
Identifying Skin Biopsy Sites
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 59
- Enrollment target
NCT01632644: Completed study, sponsored by Northwestern University.
NCT01632644 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01632644 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
The primary objective of this study is to investigate the patient experience during skin biopsy.
Primary Outcome
Subjects will answer a combination of: 1. Open-ended questions and 2. Questions asking for subject to rank possible responses
Interventions
- OTHER Survey/Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-05 |
What the finished NCT01632644 record still lists
NCT01632644 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey/Interview is the first listed.
NCT01632644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01632644 about?
NCT01632644 is a clinical study titled "Identifying Skin Biopsy Sites". The primary objective of this study is to investigate the patient experience during skin biopsy.
What is the current status of trial NCT01632644?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2012-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01632644?
The interventions under investigation include: Survey/Interview (OTHER).
Who is sponsoring clinical trial NCT01632644?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia